title: [New perspectives on depression].
abstract: Traditionally depression was considered as an episodic pathology; however, at present it is seen as a longitudinal disorder that can progress, in most of the cases, in a episodic way throughout the patient life and, in a minor percentage of patients, in a chronic way. The new longitudinal vision has changed the antidepressant treatment guidelines. The duration of the treatment of an episode has been set up in a minimum of six months. When the risk of new episodes is high, prophylactic treatment should be considered in order to keep an euthymic mood.
authors.affiliation: Departamento de Investigación Médica Lilly, S.A.
authors.forename: I
authors.initials: I
authors.lastname: Gilaberte Asín
authors.forename: T
authors.initials: T
authors.lastname: Huete Muñoz
authors.forename: B
authors.initials: B
authors.lastname: Boto Maldonado
mesh_terms: D002908:Chronic Disease; D003866:Depressive Disorder / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008376:Maprotiline / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D012008:Recurrence
chemical_list: D008996:Monoamine Oxidase Inhibitors; D008376:Maprotiline; D007099:Imipramine
vernacular_title: Nuevas perspectivas en la depresión.